Filing Details

Accession Number:
0000950170-23-064228
Form Type:
4
Zero Holdings:
No
Publication Time:
2023-11-15 17:00:14
Reporting Period:
2023-11-14
Accepted Time:
2023-11-15 17:00:14
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1816736 Disc Medicine Inc. IRON Pharmaceutical Preparations (2834) 851613057
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1951850 Rahul Khara C/O Disc Medicine, Inc.
321 Arsenal Street, Suite 101
Watertown MA 02472
General Counsel No No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2023-11-14 4,900 $14.69 4,900 No 4 M Direct
Common Stock Disposition 2023-11-14 4,113 $50.53 787 No 4 S Direct
Common Stock Disposition 2023-11-14 787 $51.05 0 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 S Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Stock Option (Right to Buy) Disposition 2023-11-15 4,900 $0.00 4,900 $14.69
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
89,804 2032-02-06 No 4 M Direct
Footnotes
  1. These transactions were effected by the Reporting Person pursuant to a Rule 10b5-1 trading plan adopted on June 22, 2023.
  2. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $50.01 to $51.00, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.
  3. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $51.01 to $51.34, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.
  4. 25% of the shares underlying this option vested on December 20, 2022, with the remaining shares vesting in 36 equal monthly installments thereafter, subject to the Reporting Person's continued service on each such vesting date.